During the past decade, Ashland Bellefonte Cancer Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 13 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 10 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ashland Bellefonte Cancer Center" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Biological Dynamics" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ashland Bellefonte Cancer Center" #1 collaborator was "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "The Physicians' Services Incorporated Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ashland Bellefonte Cancer Center" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Squamous Cell Carcinoma of the Head and Neck" (2 trials), "Advanced Breast Cancer" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Ashland Bellefonte Cancer Center" in a lesser frequency.

Most popular intervention types in "Ashland Bellefonte Cancer Center" are "Drug" (16 trials), "Other" (3 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (3 trials), "Placebo" (3 trials), "Avastin" (2 trials), "BI 695502" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ashland Bellefonte Cancer Center" are 14 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Ashland Bellefonte Cancer Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ashland Bellefonte Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ashland Bellefonte Cancer Center, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".